3 Dividend-Paying Pharma Stocks to Buy Now
These aren't the highest payouts in the industry, but they have the best chance to steadily climb.
Eli Lilly and Company
LLY
LLY
$108.64
$0.18
0.2%
BATS BZX Real Time Price as of October 18, 2019, 4:00 p.m. EDT
View Interactive LLY Charts
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
News & Analysis: Eli Lilly and Company
The Fool has written over 900 articles on Eli Lilly and Company.
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
GLP-1 drugs keep getting easier to take.
Better Buy: AbbVie vs. Eli Lilly
AbbVie and Eli Lilly have both stumbled this year. Which of these top pharma stocks is better positioned for a rebound?
4 Biotech Stocks With Big Catalysts in September
Two presentations at the World Conference on Lung Cancer will make a big difference for at least four different drugmakers.
Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?
It’s rejected a pair of drugs in the last six months.
3 Top Diabetes Stocks to Watch in August
These three diabetes-oriented companies should be on your radar right now.
Better Buy: Eli Lilly vs. GlaxoSmithKline
Which stock wins in this big-pharma matchup?
8 Stocks That Have Paid a Dividend for 125 (or More) Consecutive Years
Income stocks don't get more consistent than this.
3 Lung Cancer Stocks That Could Soar in September
These industry giants could make big moves after this year's World Conference on Lung Cancer.
Eli Lilly and Company (LLY) Q2 2019 Earnings Call Transcript
LLY earnings call for the period ending June 30, 2019.
